Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Explore the Effects of Probiotics on Endotoxin Levels in Type 2 Diabetes Mellitus Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified July 2013 by King Saud University
Sponsor:
Collaborators:
Warwick Medical School
Winclove Bio Industries BV
Information provided by (Responsible Party):
Nasser Al-Daghri, King Saud University
ClinicalTrials.gov Identifier:
NCT01765517
First received: January 1, 2013
Last updated: July 23, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2015
  Estimated Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)
No publications provided by King Saud University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):